Status:

ACTIVE_NOT_RECRUITING

PLatform Study for INTracerebral Haemorrhage (PLINTH): Community-based Feasibility Study

Lead Sponsor:

University of Edinburgh

Collaborating Sponsors:

University of the West of Scotland

University of Nottingham

Conditions:

Cerebral Hemorrhage

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this observational study is to answer three uncertainties about the design of a platform study for adults with stroke due to intracerebral haemorrhage. The main things the investigators a...

Detailed Description

Background: Clinical trials have not found a treatment that works specifically for stroke caused by bleeding in the brain, known as intracerebral haemorrhage (ICH for short). Most clinical trials have...

Eligibility Criteria

Inclusion

  • People aged ≥18 years at the time of diagnosis with symptomatic stroke due to first-ever or recurrent spontaneous (non-traumatic) ICH, most likely to be due to cerebral small vessel disease, confirmed by brain imaging between 1 October 2023 and 30 June 2025 inclusive
  • One or more management uncertainties exist about the patient's management according to the patient/nearest relative and their responsible clinician
  • Patient or their nearest relative can be approached for consent to participation in this feasibility study with the aid of simple information delivered by Tailored Talks
  • Residential postcode in the National Health Service (NHS) Lothian or NHS Lanarkshire regions of Scotland

Exclusion

  • People aged \<18 years at the time of ICH diagnosis
  • Exclusively extra-axial intracranial haemorrhage or ICH definitely attributable to a macrovascular cause (e.g. aneurysm, arteriovenous malformation, cavernoma, cerebral venous sinus thrombosis), tumour, trauma or haemorrhagic transformation of an ischaemic stroke
  • Responsible clinician deems it inappropriate to approach the patient or their nearest relative (e.g. death appears imminent)
  • Mental incapacity and no nearest relative, welfare attorney or welfare guardian available at the time of approach
  • Patient died before approached for consent

Key Trial Info

Start Date :

October 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2026

Estimated Enrollment :

169 Patients enrolled

Trial Details

Trial ID

NCT06078020

Start Date

October 1 2023

End Date

March 31 2026

Last Update

October 3 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The Royal Infirmary of Edinburgh

Edinburgh, City Of Edinburgh, United Kingdom, EH16 4SA

2

University Hospital Monklands

Airdrie, Lanarkshire, United Kingdom, ML6 0JS